| Literature DB >> 35456574 |
Justyna Chanaj-Kaczmarek1, Natalia Rosiak1, Daria Szymanowska2, Marcin Rajewski3, Ewa Wender-Ozegowska3, Judyta Cielecka-Piontek1.
Abstract
Scutellarie baicalensis radix, as a flavone-rich source, exhibits antibacterial, antifungal, antioxidant, and anti-inflammatory activity. It may be used as a therapeutic agent to treat various diseases, including vaginal infections. In this study, six binary mixtures of chitosan with stable S. baicalensis radix lyophilized extract were obtained and identified by spectral (ATR-FTIR, XRPD) and thermal (TG and DSC) methods. The changes in dissolution rates of active compounds and the significant increase in the biological properties towards metal chelating activity were observed, as well as the inhibition of hyaluronic acid degradation after mixing plant extract with chitosan. Moreover, the combination of S. baicalensis radix lyophilized extract with a carrier allowed us to obtain the binary systems with a higher antifungal activity than the pure extract, which may be effective in developing new strategies in the vaginal infections treatment, particularly vulvovaginal candidiasis.Entities:
Keywords: Scutellaria baicalensis; dissolution; spectrophotometric method; thermic method; vaginal infection
Year: 2022 PMID: 35456574 PMCID: PMC9028937 DOI: 10.3390/pharmaceutics14040740
Source DB: PubMed Journal: Pharmaceutics ISSN: 1999-4923 Impact factor: 6.525
Intermediate stability studies of S. baicalensis radix lyophilized extract.
| Compound | Residual Flavones Content (%) | |||||
|---|---|---|---|---|---|---|
| 1 Month | 2 Months | 3 Months | 4 Months | 5 Months | 6 Months | |
| baicalin | 93.03 ± 0.58 a | 91.23 ± 0.25 a | 91.25 ± 1.49 a | 90.07 ± 7.19 a | 90.76 ± 1.27 a | 90.95 ± 0.03 a |
| baicalein | 95.59 ± 0.24 a | 93.94 ± 0.55 b | 93.11 ± 0.55 b | 93.68 ± 0.96 b | 92.55 ± 0.07 b | 92.88 ± 1.02 b |
| wogonin | 92.34 ± 2.82 a | 92.26 ± 0.60 a | 92.60 ± 3.59 a | 92.78 ± 1.44 a | 91.49 ± 1.04 a | 91.76 ± 0.21 a |
The values are presented as the mean ± SD (n = 3). Mean values with the same letter are not significantly different at p < 0.05 using Duncan’s multiple range test. “a” of the alphabet stands for the highest values, “b” stands for the statistically significant decreasing values.
Figure 1ATR-FTIR spectra of S. baicalensis radix extract and the binary systems with (a) chitosan 80:500 and (b) chitosan 80:1000.
Figure 2X-ray powder diffraction (XRPD) diffraction patterns of S. baicalensis radix extract, chitosan, and the binary systems with (a) chitosan 80:500 and (b) chitosan 80:1000.
Figure 3Thermogravimetric analysis at a heating rate of 10 °C min−1 of the binary systems (a) with chitosan 80:500; (b) with chitosan 80:1000.
Figure 4DSC thermograms at a heating rate of 10 °C min−1 of the binary systems (a) with chitosan 80:500; (b) with chitosan 80:1000.
Figure 5Dissolution profiles of (a) baicalin, (b) baicalein, and (c) wogonin from pure S. baicalensis radix lyophilized radix and the binary systems.
Biological activity towards ferrous ion-chelating and hyaluronidase inhibition of S. baicalensis radix lyophilized extract, chitosans, and the binary systems.
| Extract or Chitosan System | IC50 (mg mL−1) | |
|---|---|---|
| Metal Chelating Activity | Hyaluronidase Inhibition | |
| SBE | 8.54 ± 0.13 d | 2.00 ± 0.06 d |
| SBE/Cs 80:500 2:1 | 3.27 ± 0.03 c | 0.19 ± 0.00 c |
| SBE/Cs 80:1000 2:1 | 3.11 ± 0.05 b | 0.21 ± 0.00 c |
| SBE/Cs 80:500 1:1 | 3.01 ± 0.12 a | 0.14 ± 0.00 b |
| SBE/Cs 80:1000 1:1 | 3.06 ± 0.17 a,b | 0.15 ± 0.00 b |
| SBE/Cs 80:500 1:2 | 2.97 ± 0.03 a | 0.15 ± 0.00 b |
| SBE/Cs 80:1000 1:2 | 3.14 ± 0.03 b | 0.14 ± 0.00 b |
| Cs 80:500 | n.o. | 0.03 ± 0.00 a |
| Cs 80:1000 | n.o. | 0.03 ± 0.00 a |
The results are presented as the mean ± SD (n = 6). Mean values with the same letter are not significantly different at p < 0.05 using Duncan’s multiple range test. “a” of the alphabet stands for the lowest values (the higher activity), “b–d” stand for the statistically significant increasing values. n.o.—not observed at the concentration of 1–10 mg mL−1.
Antimicrobial activity of the binary systems.
| Inhibition Zone Diameter (mm) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Microorganism | SBE (800 µg mL−1) | SBE/Cs 2:1 80/500 | SBE/Cs 2:1 80/1000 | SBE (600 µg mL−1) | SBE/Cs 1:1 80/500 | SBE/Cs 1:1 80/1000 | SBE (400 µg mL−1) | SBE/Cs 1:2 80/500 | SBE/Cs 1:2 80/1000 | Metronidazole | Clindamycin |
|
| 27.0 ± 2.0 a | 25.0 ± 2.0 a | 21.0 ± 2.0 b | 20.0 ± 1.0 b | 19.0 ± 2.0 b | 16.0 ± 2.0 c,d | 17.0 ± 2.0 c | 14.0 ± 2.0 c,d | 13.0 ± 1.0 d | 26.0 ± 1.0 a | 25.0 ± 2.0 a |
|
| 28.0 ± 2.0 a | 25.0 ± 2.0 b,c | 24.0 ± 2.0 c | 25.0 ± 2.0 b,c | 20.0 ± 2.0 d | 18.0 ± 2.0 d,e | 18.0 ± 2.0 d | 15.0 ± 1.0 e | 12.0 ± 1.0 f | 27.0 ± 1.0 a,b | 25.0 ± 2.0 b,c |
|
| 28.0 ± 3.0 a | 26.0 ± 2.0 a,b | 24.0 ± 2.0 b | 26.0 ± 3.0 a,b | 20.0 ± 2.0 c | 18.0 ± 2.0 c,d | 20.0 ± 2.0 c,d | 15.0 ± 1.0 d | 9.0 ± 1.0 e | 27.0 ± 1.0 a,b | 25.0 ± 2.0 a,b |
|
| 23.0 ± 2.0 b,c | 26.0 ± 1.0 a,b | 25.0 ± 2.0 b | 22.0 ± 2.0 c,d | 21.0 ± 2.0 c,d,e | 19.0 ± 2.0 e,f | 19.0 ± 2.0 e,f | 16.0 ± 1.0 f | 11.0 ± 1.0 g | 28.0 ± 2.0 a | 19.0 ± 2.0 d,e |
|
| 22.0 ± 2.0 a,b,c | 22.0 ± 2.0 a,b,c | 22.0 ± 2.0 a,b,c | 20.0 ± 2.0 b,c,d | 19.0 ± 2.0 c,d | 19.0 ± 2.0 d | 20.0 ± 2.0 b,c,d | 17.0 ± 1.0 d,e | 11.0 ± 1.0 f | 23.0 ± 1.0 a | 15.0 ± 1.0 e |
|
| 20.0 ± 2.0 b,c | 21.0 ± 2.0 b | 21.0 ± 2.0 b | 18.0 ± 2.0 c | 19.0 ± 2.0 b,c | 19.0 ± 2.0 b,c | 12.0 ± 2.0 e | 14.0 ± 1.0 d | 11.0 ± 1.0 e | 20.0 ± 1.0 b,c | 25.0 ± 2.0 a |
|
| 19.0 ± 0.0 a | 16.0 ± 1.0 b,c | 19.0 ± 1.0 a | 17.0 ± 0.0 b | 15.0 ± 1.0 c | 15.0 ± 1.0 c | 11.0 ± 0.0 d | 15.0 ± 1.0 c | 11.0 ± 1.0 d | 16.0 ± 1.0 b,c | 19.0 ± 2.0 a |
|
| 15.0 ± 0.0 b | 16.0 ± 1.0 b | 18.0 ± 2.0 a | 13.0 ± 0.0 c | 16.0 ± 1.0 b | 18.0 ± 2.0 a | 11.0 ± 0.0 d | 15.0 ± 1.0 b | 12.0 ± 1.0 c,d | 18.0 ± 1.0 a | 15.0 ± 1.0 b |
|
| 13.0 ± 0.0 d,e | 17.0 ± 1.0 c | 22.0 ± 1.0 b | 11.0 ± 0.0 f,g | 17.0 ± 2.0 c | 18.0 ± 2.0 c | 10.0 ± 0.0 g | 14.0 ± 1.0 d | 12.0 ± 1.0 e,f | 18.0 ± 1.0 c | 25.0 ± 2.0 a |
|
| 12.0 ± 0.0 f | 18.0 ± 1.0 d | 20.0 ± 1.0 c | 12.0 ± 0.0 f | 15.0 ± 1.0 d | 18.0 ± 1.0 d | 10.0 ± 0.0 g | 13.0 ± 1.0 f | 12.0 ± 1.0 f | 27.0 ± 2.0 a | 25.0 ± 2.0 b |
All the binary systems were tested at a concentration of 1200 µg mL−1. Reference substances, such as metronidazole and clindamycin, were tested at a concentration of 1000 µg mL−1. The results are presented as the mean ± SD (n = 3). Mean values with the same letter are not significantly different at p < 0.05 using Duncan’s multiple range test. “a” of the alphabet stands for the highest values, “b–g” stand for the statistically significant decreasing values.